Distalmotion accelerates U.S. ASC rollout of Dexter robotic surgery platform

New updates have been reported about Distalmotion.

Distalmotion is expanding the U.S. commercialization of its Dexter robotic surgery system, reporting rising adoption across ambulatory surgery centers (ASCs) as procedures continue to migrate from hospitals to outpatient settings. The company is positioning Dexter as an ASC-native platform that removes infrastructure, workflow, and cost barriers that have historically limited robotic uptake outside large hospital systems.

The system’s compact, mobile design and open architecture allow ASCs to use existing operating rooms and visualization equipment, avoiding the capital burden of closed, ecosystem-based robotic solutions. CEO Greg Roche said U.S. centers are looking for robotics that enhance efficiency and flexibility rather than add complexity, and that Dexter is intended to support practical, sustainable ASC robotic programs.

As part of this strategy, Distalmotion is driving deployment of Dexter into ASCs affiliated with major national healthcare organizations, including CommonSpirit Health, HonorHealth, SCA, and Surgery Partners. Cypress Surgery Center has become the first Surgery Partners facility in its region to launch a robotic program with Dexter, citing a financial model that finally aligns robotics with ASC economics and preserves high-throughput workflows.

For ASCs, Distalmotion’s value proposition centers on a sterile surgeon console that keeps the surgeon at the bedside, enabling rapid transitions between laparoscopic and robotic techniques and minimizing setup and turnover time. The company emphasizes that Dexter’s single-use, fully wristed instruments and short learning curve are designed to streamline training and operations, supporting faster integration into routine practice.

Regulatory indications also shape the commercial opportunity: in Europe, Dexter is cleared for urologic, general, and gynecologic laparoscopic procedures in adults, while in the U.S. it is currently indicated for adult laparoscopic inguinal hernia repair, cholecystectomy, benign total hysterectomy, and salpingo-oophorectomy. Distalmotion, headquartered in Lausanne with a U.S. base in Cleveland, is targeting both hospital outpatient departments and ASCs to broaden access to minimally invasive robotic surgery, with the current U.S. ASC momentum underscoring its strategic focus on cost-sensitive, high-efficiency sites of care.